Hong Kong-listed biotech stocks rallied in early trading, with BeiGene (06160.HK) rising over 2%, followed by gains in Hansoh Pharmaceutical (03692.HK), Zai Lab (09688.HK), Kelun Biotech (06990.HK), CSPC Pharmaceutical Group (01093.HK), and WuXi AppTec (02359.HK).